HAWKTAIL β 2024 Investments
6 investments dated 2024 Β· listed companies and verified rows first Β· show all
Seaport Therapeutics develops therapeutics and medicines.
BiotechMental HealthBoston, US
Daphne Zohar(Founder, CEO and Board Member)inMichael Chen(Executive Officer)Lana Gladstein(Executive Officer)Antony Loebel(Executive Officer)Eric Green(Executive Officer)
BoardJames I. Healy(Director)
Co-investorsARCH Venture PartnersForesite CapitalPureTech HealthSofinnova Ventures
Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders.
AI & Machine LearningBiotechDeep TechLos Altos, US
Michael Horowitz(Executive Officer, Director)Mike Horowitz(CEO & Co-founder)Justin Ichida(Co-founder)Scott Patterson(CTO & Co-founder)Joe Wagner(Chief Development Officer)
Board seatAlda Leu DennisΒ· per SEC Form D
Co-investorsCantos VenturesSpacecadet VenturesBiovergeBuilders VCInitialized CapitalRefactor Capital
BurnBot builds purpose-built, remotely controlled machines and services for wildfire mitigation, fuels management, vegetation control, and timber operations.
CleantechClimate TechHardwareRoboticsSouth San Francisco, US
Waleed Haddad(Executive Officer, Director)
BoardAnukool Lakhina(Executive Officer, Director)in
Co-investorsAmerican Family VenturesConvective CapitalDBL PartnersDCVC (Data Collective)Ecosystem Integrity FundLOWERCARBON+8 more
HoX builds integrated systems that automate laboratory operations across the bioeconomy, handling everything from sample sequencing to building AI-native, multimodal data records.
AI & Machine LearningBiotechData & InfrastructureSpokane, US
James van Alstine(Executive Officer, Director)Philip Hofer(Director)
Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.
AI & Machine LearningBiotechMedical DevicesNew York, US
Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Neville Sanjana(Director)Mat Legut(Founder)in
BoardVasudev Bailey(Director)in
Co-investorsArtis VenturesCivilization Ventures Management, LlcFusionWingAlexandriaGaingels+1 more
Siren Biotechnology develops next-generation AAV (adeno-associated virus) platforms for gene therapy applications, including gene repair, gene transfer, and gene editing.
BiotechDigital HealthMedical DevicesSan Francisco, US
Dr. Nicole Paulk(CEO, Founder, and President)Nicole Paulk(Executive Officer, Director)Lauren Kelly(Founder)inSharon Tetlow(Director)Brad Allen(Director)
Co-investorsArtis VenturesAvilaCarnrite VenturesCivilization Ventures Management, LlcNZVCPlum Alley Investments+2 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.